Physician

Ahmad Hussein Ali, M.D.

According to 2025 Medicare claims, Ahmad Ali, M.D. (NPI: 1538337860) practices endocrinology in the Orlando-Kissimmee-Sanford, FL market, with the plurality of this provider's patient population coming from Orange, FL. This provider's primary affiliated billing organization is DIABETES THYROID AND ENDOCRINE ADVANCED CARE INC (NPI: 1700281813; TIN: 472207961) and primary practice location at 32792-3532.

Ali's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 396 traditional Medicare patients, billed 1,311 HCPCS/CPT codes, and received $109,723 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 5,510 prescription claims across 611 beneficiaries totaling $2,760,862 in drug costs, led by Ozempic (Semaglutide). DME data shows 520 claims. Open Payments data shows 118 records totaling $2,276. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $25,820 to $109,723. Similarly, Part D prescription costs have risen steadily, from $403,412 to $2,760,862. For DME billing, reported payments moved sharply higher in recent years, from $21,073 to $193,167.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	115	298	$25,820
2016	183	492	$37,149
2017	223	591	$41,808
2018	268	692	$45,835
2019	316	868	$57,392
2020	330	915	$67,741
2021	406	1,032	$92,740
2022	357	916	$78,466
2023	382	1,250	$95,722
2024	396	1,311	$109,723

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	348	1,620	$403,412
2016	317	2,357	$670,036
2017	425	3,554	$1,078,271
2018	504	4,366	$1,577,149
2019	589	5,351	$2,226,684
2020	629	5,805	$2,549,377
2021	676	6,047	$2,958,184
2022	689	5,529	$2,867,354
2023	629	5,532	$3,146,244
2024	611	5,510	$2,760,862

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	185	424	$30,826
2016	113	321	$15,969
2017	104	349	$42,879
2018	116	405	$50,562
2019	136	454	$84,670
2020	208	740	$150,586
2021	199	960	$186,476
2022	128	905	$184,734
2023	125	896	$182,595
2024	124	520	$193,134

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	15	15	$172
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	68	76	$139
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	58	58	$119
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	368	933	$91
G0444	Annual depression screening, 5 to 15 minutes	212	212	$18

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	323	17,898	$576,719
Jardiance	Empagliflozin	238	16,876	$324,485
Trulicity	Dulaglutide	146	7,040	$231,610
Mounjaro	Tirzepatide	101	4,424	$162,452
Soliqua 100-33	Insulin Glargine/Lixisenatide	82	4,900	$120,667

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	85	359	$172,520
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	N/R	24	$5,473
A4238	Supply allowance for adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	11	$5,080
E0784	External ambulatory infusion pump, insulin	Y	N/R	13	$4,030
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	14	14	$2,978

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	118	$2,276	CeQur Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ahmad Hussein Ali, M.D.?

Tedicare shows public-source Medicare data for Ahmad Hussein Ali, M.D. (NPI 1538337860), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmad Hussein Ali, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ahmad Hussein Ali, M.D.?

Ahmad Hussein Ali, M.D. is linked to DIABETES THYROID AND ENDOCRINE ADVANCED CARE INC (billing NPI 1700281813) in the available physician profile data.

Does Ahmad Hussein Ali, M.D. have Open Payments data?

Ahmad Hussein Ali, M.D. has 118 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.